US Patent 10167471 Inhibition of PCSK9 through RNAI
Patent 10167471 was granted and assigned to Rxi Pharmaceuticals Corporation on January, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10167471 Inhibition of PCSK9 through RNAI
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.